Allogeneic CD19-CAR-T cell infusion after allogeneic hematopoietic stem cell transplantation in B cell malignancies. - Wikidata - wikimedia - TriplyDB

Allogeneic CD19-CAR-T cell infusion after allogeneic hematopoietic stem cell transplantation in B cell malignancies.

Allogeneic CD19-CAR-T cell infusion after allogeneic hematopoietic stem cell transplantation in B cell malignancies.

http://www.wikidata.org/entity/Q37615772

about

Single- or double-unit UCBT following RIC in adults with AL: a report from Eurocord, the ALWP and the CTIWP of the EBMT Chimeric antigen receptor T cells: a novel therapy for solid tumors.Novel immunotherapies for adult patients with B-lineage acute lymphoblastic leukemia Engineering CAR-T cells.Chimeric antigen receptors for adoptive T cell therapy in acute myeloid leukemia Chimeric-antigen receptor T (CAR-T) cell therapy for solid tumors: challenges and opportunities.CAR-T cells and allogeneic hematopoietic stem cell transplantation for relapsed/refractory B-cell acute lymphoblastic leukemia.Human Pluripotent Stem Cells to Produce Cell-based Cancer Immunotherapy.CD19 CAR-T cell therapy for relapsed/refractory acute lymphoblastic leukemia: factors affecting toxicities and long-term efficacies.Genetically enhanced T lymphocytes and the intensive care unit.Immune Cell Hacking: Challenges and Clinical Approaches to Create Smarter Generations of Chimeric Antigen Receptor T Cells The functional verification of EGFR-CAR T-cells targeted to hypopharyngeal squamous cell carcinoma Simple deep sequencing-based post-remission MRD surveillance predicts clinical relapse in B-ALL

P2860

Q33820379-8A159D40-951E-487B-B0C5-47BDFFD738FF Q37728639-415F7EA9-6361-4C23-AACA-47C9B63727CA Q38640263-1C843D1E-45AA-4883-AD12-1621BFA53A63 Q39399864-07E4B890-6D67-4069-A65B-7F315F63C726 Q41558781-A19F822B-D03E-4338-BCA9-576271C6CE14 Q45832774-C5268F4F-31BB-4D69-A120-77F12E935DA2 Q46018826-C6E5B66A-22E1-4F85-AFC1-27D7900A436A Q46350666-873D105F-B256-4CB6-93A9-ECD38731CAB0 Q55193924-CC60107E-67FA-4484-931D-AB7610786F0C Q55380614-54939D70-FE05-40BD-9BC2-B33884F5E9A8 Q57173949-A87E41C1-4AF0-412E-BD60-2E3E1BFE7FC3 Q58558222-28F73496-8230-46F4-8494-CEC4DC5847B3 Q58724470-29190B27-9284-4CB4-B9B2-F86A22FCA04F

P2860

Allogeneic CD19-CAR-T cell infusion after allogeneic hematopoietic stem cell transplantation in B cell malignancies.

http://www.wikidata.org/entity/Q37615772

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 31 January 2017

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Allogeneic CD19-CAR-T cell inf ...... tation in B cell malignancies.

@en

Allogeneic CD19-CAR-T cell inf ...... tation in B cell malignancies.

@nl

type

label

Allogeneic CD19-CAR-T cell inf ...... tation in B cell malignancies.

@en

Allogeneic CD19-CAR-T cell inf ...... tation in B cell malignancies.

@nl

prefLabel

Allogeneic CD19-CAR-T cell inf ...... tation in B cell malignancies.

@en

Allogeneic CD19-CAR-T cell inf ...... tation in B cell malignancies.

@nl

P1433

Q37615772-CA6318EA-C0AE-4801-96DC-37BFC79E2C6D

P1476

Q37615772-08F3BB9A-0123-4F04-B058-9C22D97EE14D

P2093

Q37615772-1013C936-29A0-490B-89B7-C4DAD9A10D60

Q37615772-56DF3A4C-8AFB-43A4-A9B4-C7BAC9C5E994

Q37615772-7A8AEE17-2AFB-4968-AAF1-95E7F56EA0AB

Q37615772-9C629EC4-0DC6-4C2B-B3D2-982B57E41330

P275

Q37615772-BDB41BF9-88E3-4299-A7C4-9946E4A1165D

P2860

Q37615772-07821793-AC04-448C-935B-7C93C82A6C0A

Q37615772-09F17EB4-455E-4311-A91C-D77290A9FFD4

Q37615772-0EA4D90A-E516-4E1E-8A11-DCC84D2F037E

Q37615772-1402B0BA-F305-4BF5-90B9-30ACCFD703D2

Q37615772-19808053-098B-4023-8952-F93D0CECD353

Q37615772-269492D6-C492-46D0-BDE4-A47D2CBEB5E2

Q37615772-26E5A674-F7B0-468E-8822-FAD617DEEFF3

Q37615772-2BF8382D-4C71-462B-93E8-363B69F2777D

Q37615772-2C8A1F37-7A7F-4B1C-8C13-68646EBABDEB

Q37615772-2D1E28B8-9D2E-4073-8C95-7B143D48EC1B

P2888

Q37615772-DE9D2B86-3EEA-442C-A5D6-9F1964CD8D65

P304

Q37615772-968070D9-9D5D-4A03-83B5-F8B38B5F172C

P31

Q37615772-0A1756ED-4EC6-4D0E-9369-82C2E481FAF2

Q37615772-F545412B-8832-4530-8542-C632D712A387

P356

Q37615772-C94BC3E1-A2CA-4708-94E8-92A38BD5B898

P433

Q37615772-AB90B93A-B891-42EE-B72C-45A177D51EAD

P478

Q37615772-DA837DC3-CD3B-493A-8C2A-5F799AFC3AB2

P5008

Q37615772-8E6BE9EF-5635-47CE-BF10-3A1E04339EBD

P577

Q37615772-D7FAE1E7-3611-4050-AB35-93065B5F22E7

P6179

Q37615772-BC0B214F-8DC2-433F-8514-9B21120C1DF2

P698

Q37615772-AD05700F-B0CA-4765-AF47-5C59C06696D9

P921

Q37615772-69D44577-0E19-46D1-B60F-1CBF2A2A9733

Q37615772-A20C681B-201B-460F-ADC3-5E20881ADE15

Q37615772-D0DA58E5-BF68-4AE8-984B-792D87BA8F55

P932

Q37615772-91903353-9056-44E3-81B2-C49DE9965FCE

P356

S13045-017-0405-3

P1433

Journal of Hematology & Oncology

P1476

Allogeneic CD19-CAR-T cell inf ...... tation in B cell malignancies.

@en

P2093

Cheng Zhang

http://www.w3.org/2001/XMLSchema#string

Jiang F Zhong

http://www.w3.org/2001/XMLSchema#string

Jun Liu

http://www.w3.org/2001/XMLSchema#string

Xi Zhang

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia

T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia

The role of blinatumomab in patients with relapsed/refractory acute lymphoblastic leukemia

Current status and perspectives in translational biomarker research for PD-1/PD-L1 immune checkpoint blockade therapy

Blinatumomab: a bispecific T cell engager (BiTE) antibody against CD19/CD3 for refractory acute lymphoid leukemia

CD19-targeted chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia

Chimeric antigen receptor T cells for sustained remissions in leukemia

Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia

Chimeric antigen receptor-modified T cells for acute lymphoid leukemia

CD19-targeted T cells rapidly induce molecular remissions in adults with chemotherapy-refractory acute lymphoblastic leukemia

P2888

s13045-017-0405-3

P304

35

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S13045-017-0405-3

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P5008

P577

2017-01-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1083399660

http://www.w3.org/2001/XMLSchema#string

P698

28143567

http://www.w3.org/2001/XMLSchema#string

P921

hematologic cancer

biomedical investigative technique

hemic and immune systems

P932

5282795

http://www.w3.org/2001/XMLSchema#string